4-(4'-Methyl-[2,2'-bipyridin]-4-yl)butanoic acid, 95.0%, 500mg

Chloroacetic acid ethyl ester, >=98%, for synthesis, 1 L, glass packaging

(2E)-1-(2,4-dimethoxyphenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

Bis(2,4-dimethylphenyl)amine, 95.0%, 1g

Sodium Metaphosphate500g

Methyl 6-chloro-5-methylpicolinate, 95.0%, 5g

1-Benzhydrylazetidin-3-yl 3-amino-3-iminopropanoate acetate, 95.0%, 25g

6-(tert-butyl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 500mg

3-Bromo-N-isopropylbenzamide, 95.0%, 5g

N-(2-CHLORO-5-NITROPHENYL)BENZAMIDE, 95.0%, 250mg

4-bromo-1-methyl-1H-indazol-3-amine, 25g

5',5'''-Bis(4-carboxyphenyl)-5''-(4,4''-dicarboxy-[1,1':3',1''-terphenyl]-5'-yl)-[1,1':3',1'':3'',1''':3''',1''''-quinquephenyl]-4,4''''-dicarboxylic acid, 98%, 1g

2,6-Dibromo-N,N-dimethylpyridin-4-amine, 95.0%, 250mg